Compare VRAX & MEGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VRAX | MEGL |
|---|---|---|
| Founded | 2013 | 2016 |
| Country | United Kingdom | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7M | 5.1M |
| IPO Year | 2021 | 2021 |
| Metric | VRAX | MEGL |
|---|---|---|
| Price | $0.15 | $1.07 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $1.00 | N/A |
| AVG Volume (30 Days) | ★ 6.0M | 12.7K |
| Earning Date | 03-10-2026 | 04-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $217,274.83 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.13 | $0.87 |
| 52 Week High | $1.34 | $2.62 |
| Indicator | VRAX | MEGL |
|---|---|---|
| Relative Strength Index (RSI) | 37.65 | 58.65 |
| Support Level | N/A | $1.01 |
| Resistance Level | $0.25 | $1.13 |
| Average True Range (ATR) | 0.02 | 0.03 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 10.14 | 71.32 |
Virax Biolabs Group Ltd is an inventive biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Through its ViraxImmune platform and ImmuneSelect portfolio of research-use-only (RUO) products and services, the Company is building an immune-profiling offering that spans RUO assays, preclinical immunology services and, longer term, T cell-based diagnostics aimed at post-acute infection syndromes (PAIS) such as Long COVID and other chronic conditions linked to immune dysregulation.
Magic Empire Global Ltd is a financial services provider in Hong Kong which principally engage in the provision of corporate finance advisory services and underwriting services. The companys offerings mainly comprise of IPO sponsorship services, Financial advisory and independent financial advisory services, Compliance advisory services, Underwriting services, Corporate service.